Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05519774 · ClinicalTrials.gov registry record
Assessment of Cancer Related Brain Fog Using the Test of Strategic Learning
A clinical trial, sponsored by Inova Health Care Services.
- Completed
- Registry status
- 54
- Enrollment target
NCT05519774: Completed study, sponsored by Inova Health Care Services.
NCT05519774 is a clinical trial that has completed, run by Inova Health Care Services. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05519774 has completed, sponsored by Inova Health Care Services.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The Inova research team will ask people who have had an experience of breast cancer and related changes to their cognition to complete some scales that researchers have established describe brain fog (called patient reported outcomes) and compare those results to the TOSL results. This will be done twice to see if changes are detected similarly on both types of measures.
Primary Outcome
Number of months between opening of recruitment and recruitment date of the 10th subject.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2024-10-18 |
What the finished NCT05519774 record still lists
NCT05519774 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05519774 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05519774 about?
NCT05519774 is a clinical study titled "Assessment of Cancer Related Brain Fog Using the Test of Strategic Learning". The Inova research team will ask people who have had an experience of breast cancer and related changes to their cognition to complete some scales that researchers have established describe brain fog (called patient reported outcomes) and compare those results to the TOSL results. This will be done ...
What is the current status of trial NCT05519774?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2022-08-01. Estimated completion is 2024-10-18.
Who is sponsoring clinical trial NCT05519774?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI